Startups
3C Bio builds and operates mobile SARS-CoV-2 testing labs for high throughput on-site event or workplace screening.
Overview
Location
United States, California, Los Angeles
Phone
+1 888-322-4601
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 13, 2021 | IVERIC bio, Inc. : Announces Pricing of $100 Million Public Offering of Common Stock | IVERIC bio, Inc. (Nasdaq: ISEE) (the “Company”), today announced the pricing of an underwritten public offering of 11,650,000 shares of its common stock at a price to the public of $8.60 per share, less underwriting discounts and commission... |
| Aug 18, 2020 | ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing | |
| Aug 18, 2020 | ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing |
Reviews 0
FAQ about 3C Bio, Inc.
What has the press written about 3C Bio, Inc.?
Parsers VC has collected 4 articles mentioning 3C Bio, Inc., among them “IVERIC bio, Inc. : Announces Pricing of $100 Million Public Offering of Common Stock” (Jul 13, 2021) and “ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing” (Aug 18, 2020).
Is 3C Bio, Inc. still active?
3C Bio, Inc. is probably closed: its latest activity on Parsers VC dates from Nov 1, 2021.